Introduction
Status epilepticus (SE) affects 120,000-200,000 Americans per year, of which 25-50% may be considered non-convulsive SE.
1 SE is life-threatening condition, with a mortality rate of 1.9 to as high as 40%, depending on the population studied. 2 Due to its high mortality and morbidity, multiple approaches have been suggested to treat SE, including general anesthesia. However, in spite of putting patients into comatose state under general anesthesia or barbiturates, mortality rate is still high, about 20%. 3 Although definitions of refractory SE vary, it is thought to occur between 10-70% of cases. 4 Electroconvulsive therapy (ECT) has been employed successfully as a treatment for refractory epilepsy and SE after exhausting conventional therapy. [4] [5] [6] However, ECT use in pediatric patients is limited, even in psychiatric illness. 7 In a limited previous case series of ECT treatment in pediatric patients for refractory epilepsy, AED were halt during the ECT course. 6 We describe a pediatric case in which ECT was used successfully to treat medically refractory nonconvulsive status epilepticus (NCSE) while the AED were continued.
Case report

History
A 7-year-old female with cerebral palsy, extensive bilateral polymicrogyria throughout both hemispheres predominately involving the medial parietal lobes and lesser degree to bilateral frontal lobes and right insula/superior temporal lobe, developmental delay, and intractable epilepsy with previous treatment with ketogenic diet and phenobarbital was admitted to our Epilepsy Monitoring Unit (EMU). On the day of admission to EMU, she developed NCSE with generalized spike and waves 1-2 Hz while on valproate, levetiracetam and clobazam (Fig. 1A) . Multiple intravenous loads of benzodiazepam, levetiracetam, phenobarbital did not halt her NCSE.
Medical treatment
She was transferred to the pediatric intensive care unit for further management of her NCSE on hospital day 1. Burst suppression was achieved on hospital day 2 with a combination of concomitant intravenous anesthetics, including with midazolam drip, pentobarbital drip, ketamine drip, topiramate load, and high dose steroid as well as continuation of AEDs on admission. She remained in burst suppression for the next 12 days. Electrographic seizures recurred when attempting to wean her from high dose anesthetic therapy. Status epilepticus is a life threatening condition with a high mortality rate in spite of aggressive treatment. There is little consensus on third and fourth line approaches in refractory cases. While electroconvulsive therapy (ECT) has been employed successfully as a treatment for refractory epilepsy and status epilepticus (SE) after exhausting conventional therapy, its use for pediatric patients is limited. We describe a 7-year-old pediatric case in which ECT was used successfully to treat medically refractory nonconvulsive status epilepticus (NCSE) without complete withdrawal of antiepileptic drugs (AED).
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ECT treatment
After unsuccessful attempts to wean from drug induced coma due to return of NCSE, ECT treatment was initiated on hospital day 14 with parental consent. The pediatric anesthesia team pretreated with atropine and rocuronium and vitals remained stable throughout the ECT course. Bitemporal electrode placement was selected to produce the most generalized seizure, given the lack of a clear seizure focus. A single frontal-mastoid EEG recording montage was employed using the MECTA ECT device, as the ECT stimulus would be damaging to the amplifiers used for full EEG monitoring. She received two consecutive ECT sessions with three stimuli at each session over 2 days (Hospital Day 14 and 15); then two more sessions one week later (hospital day 21 and 22) ( Table 1) . A number of different stimulus parameters were employed as described in Table 1 . Pentobarbital and ketamine drips were weaned off during her ECT sessions. Midazolam was reversed with flumazenil prior to each session in order to lower seizure threshold for ECT induced generalized seizure. However, valproic acid, topiramate, levetiracetam, and clonazepam were continued during ECT sessions.
Response to ECT
NCSE was terminated initially after two sessions on successive days with three stimulations per day. Two days after initial cessation of her seizure, NCSE with beta frequency returned and continued for five days despite multiple medical interventions. Based upon the initial promising results with ECT, she received an additional successful six stimulations one week following the first series (Table 1) .
Fourteen hours after her final series of ECT treatments, her NCSE was stopped with generalized slowing and BIPLEDs in EEG (Fig. 1B and Table 1 ). Her AEDs were successfully weaned to valproate, topiramate, levetiracetam, and clobazam. Over the three weeks following her last ECT treatment, multiple routine inpatient EEGs showed complete resolution of BIPLEDs but intermittent infrequent 2-4 Hz generalized spike and wave. Subsequently, her mental status also improved. She was awake and interactive. Three weeks after final ECT and weaning of medicine, she was able to go home with infrequent absence seizures and moderate encephalopathy.
Post hospital outcome
Eleven weeks after discharge from hospital, her outpatient EEG improved with rare left frontotemporal spikes without subclinical seizure (Fig. 1C) . Her mental status improved further. Unfortunately, she passed away suddenly several weeks later likely from sudden unexpected death in epilepsy (SUDEP).
Discussion
Electroconvulsive therapy (ECT) has been employed successfully as a treatment for refractory epilepsy and SE after exhausting conventional therapy. [4] [5] [6] However, the exact mechanism for ECT to anticonvulsive effect is not clear. Multiple theories have been suggested. The most commonly accepted thought is its GABAnergic effect. Electroconvulsive shock in animals is associated with the engagement of strong anticonvulsant mechanisms, probably mediated by GABA. These anticonvulsant effects build and accumulate with repeated induced-seizures given over several days, and the effect persists for days up to a few weeks after ECT is over. 8, 9 The seizure threshold, as measured in the amount of electrical charge that is required to produce a seizure, increases over the course of ECT, as the anti-convulsant mechanisms takes hold. In neurologically intact depressed adults, it is clear that the degree of EEG-seizure generalization is dependent upon location of the stimulus electrodes, as well as the electrical dose. 10 Further, the efficiency at which a given amount of electrical charge will induce a seizure varies as a function of the specific electrical parameters of current, pulse width, frequency of stimuli, and stimulus train duration. For these reasons, stimulus parameters may vary over a course of ECT. Despite the effectiveness of ECT in SE, very few cases have been reported in the literature. Griesemer reported one pediatric case series on the use of ECT to treat two children with refractory epilepsy. The first patient was a 13-year-old boy with microgyria and intractable epilepsy despite multiple AEDs with frequent seizures. He received four sessions of ECT treatment over 9 days with mild improvement in seizure frequency and severity. One year later, NCSE in the same patient was halted by three daily sessions of ECT. He also reported successful ECT outcome on a 10-year-old girl with micricephaly and intractable epilepsy despite AEDs after six sessions of ECT over two weeks. However, in both cases, AEDs were either held or completely stopped before the ECT treatment. 6 To our knowledge, this is the first report for successful ECT treatment on pediatric NCSE with continuation of AED. Our patient unfortunately succumbed to unexpected SUDEP within six months of successful treatment of SE. Even though our patient died from SUDEP, ECT played an important role in achieving remission from refractory status epilepticus, allowing her and her family several months of respite from a severe epileptic disease. Also unknown is whether an earlier initiation of ECT therapy might have shortened the duration of SE and whether this would have improved our patient's long-term outcome.
ECT may be useful for treatment of pediatric refractory status epilepticus as demonstrated in our case, even in the absence of a full ECT-induced generalized seizure and when it may be considered too risky to fully withdraw antiepileptic drugs. Further prospective studies of ECT in status epilepticus may be useful in this condition. The number of treatments needed, as well as the optimal ECT stimulus characteristics, and the possible role of earlier initiation of ECT to render better outcomes are among the questions to be answered.
